Viale P; Pea F, Capitolo 142 - Scelta dell'antibiotico nel malato critico, in: Medicina Critica, ITA, UTET Divisione Scienze Mediche, 2010, pp. 1221 - 1233 [commento giuridico]
Arlotti M.; Grossi P.; Pea F.; Tomei G.; Vullo V.; De Rosa F.G.; Di Perri G.; Nicastri E.; Lauria F.N.; Carosi G.; Moroni M.; Ippolito G., Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses, «INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES», 2010, 14, pp. S79 - S92 [articolo]
Pea F; Furlanut M; Viale P, Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function?, «THE JOURNAL OF TRAUMA, INJURY, INFECTION, AND CRITICAL CARE», 2010, 68, pp. 748 - 749 [articolo]
Pea F; Furlanut M; Cojutti P; Cristini F; Zamparini E; Franceschi L; Viale P., Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis., «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2010, 54, pp. 4605 - 4610 [articolo]
Pea, Federico; Viale, Pierluigi, Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?, «CRITICAL CARE», 2009, 214, pp. 1 - 13 [articolo]
Pea F; Viale P; Lugano M; Baccarani U; Pavan F; Tavio M; Adani GL; Della Rocca G; Furlanut M., Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2009, 63, pp. 167 - 169 [articolo]
Pea F; Furlanut M, Chapter 219 - Principles of pharmacodynamics and pharmacokinetics of drugs used in extracorporeal therapies, in: Critical Care Nephrology - 2nd edition, USA, Saunders Elsevier, 2009, pp. 1190 - 1194 [commento giuridico]
Pea F; Viale P, Could de-escalation of antibiotic therapy be feasible even for documented methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia?, «THE JOURNAL OF TRAUMA, INJURY, INFECTION, AND CRITICAL CARE», 2009, 66, pp. 348 - 1343 [articolo]
Pea F; Viale P, Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring?, «THERAPEUTIC DRUG MONITORING», 2009, 21, pp. 135 - 136 [replica/breve intervento]
Pea F; Furlanut M; Viale P, Is antimicrobial underexposure due to glomerular hyperfiltration a possible cause of increased mortality rate from bacterial infections in critically ill patients?, «ANAESTHESIA AND INTENSIVE CARE», 2009, 37, pp. 323 - 324 [articolo]
Pea F.; Viale P., Is the minimum inhibitory concentration of vancomycin an infallible predictor of the clinical outcome of staphylococcus aureus bacteremia treated with vancomycin?, «CLINICAL INFECTIOUS DISEASES», 2009, 49, pp. 642 - 643 [replica/breve intervento]
Pea F., Penetration of antibacterials into bone: What do we really need to know for optimal prophylaxis and treatment of bone and joint infections?, «CLINICAL PHARMACOKINETICS», 2009, 48, pp. 125 - 127 [replica/breve intervento]
Pea F.; Furlanut M.; Negri C.; Pavan F.; Crapis M.; Cristini F.; Viale P., Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2009, 53, pp. 1863 - 1867 [articolo]
Scaglione F.; Bertazzoni Minelli E.; De Sarro A.; Esposito S.; Legnani D.; Mazzei T.; Mini E.; Passali D.; Pea F.; Stefani S.; Viano I.; Novelli A., The Charta of Milan: Basic criteria for the appropriate and accurate use of antibiotics: Recommendations of the Italian society of chemotherapy, «JOURNAL OF CHEMOTHERAPY», 2009, 21, pp. 475 - 481 [articolo]
Viale P.; Furlanut M.; Scudeller L.; Pavan F.; Negri C.; Crapis M.; Zamparini E.; Zuiani C.; Cristini F.; Pea F., Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2009, 33, pp. 379 - 382 [articolo]
